Baird Financial Group’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-118,865
| Closed | -$10.8M | – | 1592 |
|
|
2019
Q3 | $10.8M | Sell |
118,865
-7,189
| -6% | -$683K | 0.04% | 341 |
|
|
2019
Q2 | $11.7M | Sell |
126,054
-2,674
| -2% | -$254K | 0.05% | 335 |
|
|
2019
Q1 | $12.1M | Sell |
128,728
-111,611
| -46% | -$9.76M | 0.07% | 283 |
|
|
2018
Q4 | $15.4M | Sell |
240,339
-139,200
| -37% | -$10.3M | 0.1% | 236 |
|
|
2018
Q3 | $34.1M | Buy |
379,539
+29,037
| +8% | +$2.57M | 0.21% | 136 |
|
|
2018
Q2 | $27.8M | Sell |
350,502
-8,058
| -2% | -$669K | 0.19% | 153 |
|
|
2018
Q1 | $32M | Buy |
358,560
+40,496
| +13% | +$3.89M | 0.23% | 132 |
|
|
2017
Q4 | $33.2M | Sell |
318,064
-103,120
| -24% | -$11.6M | 0.24% | 126 |
|
|
2017
Q3 | $61.4M | Buy |
421,184
+5,503
| +1% | +$750K | 0.46% | 43 |
|
|
2017
Q2 | $54M | Buy |
415,681
+19,997
| +5% | +$2.45M | 0.42% | 49 |
|
|
2017
Q1 | $49.2M | Buy |
395,684
+11,923
| +3% | +$1.43M | 0.4% | 52 |
|
|
2016
Q4 | $44.4M | Buy |
383,761
+20,461
| +6% | +$2.28M | 0.39% | 62 |
|
|
2016
Q3 | $38M | Buy |
363,300
+12,051
| +3% | +$1.3M | 0.34% | 80 |
|
|
2016
Q2 | $34.7M | Buy |
351,249
+60,065
| +21% | +$6.21M | 0.32% | 86 |
|
|
2016
Q1 | $29.1M | Buy |
291,184
+53,951
| +23% | +$5.56M | 0.28% | 105 |
|
|
2015
Q4 | $28.4M | Sell |
237,233
-12,281
| -5% | -$1.42M | 0.28% | 102 |
|
|
2015
Q3 | $27M | Sell |
249,514
-19,025
| -7% | -$2.36M | 0.29% | 102 |
|
|
2015
Q2 | $31.1M | Buy |
+268,539
| New | +$30.7M | 0.31% | 103 |
|
Other funds holding CELG
Baird Financial Group's CELG Position: Q4 2019 in Review
Baird Financial Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 118,865 shares — an estimated $10.8M sold.
Baird Financial Group first reported a position in CELG in Q2 2015 and held it in 18 quarters. The position peaked at $61.4M in Q3 2017. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Baird Financial Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Baird Financial Group sold 118,865 Celgene Corp shares in Q4 2019, an estimated $10.8M.
- Baird Financial Group first reported a position in Celgene Corp in Q2 2015 and held it in 18 quarters.
- Baird Financial Group's Celgene Corp position peaked at $61.4M in Q3 2017.
- 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Baird Financial Group's 13F filing for Q4 2019, filed 14 Feb 2020.